HLA typing Jun 5, 2021 Engineered TCR Therapy Demonstrates Durable Responses in Rare Sarcomas Apr 10, 2021 Immunocore's Tebentafusp Prolongs Survival in Uveal Melanoma Patients, AACR Study Shows Premium Nov 16, 2020 Somatic Mutations in Lung Cancer Patients With HLA Supertype B44 Influence Immunotherapy Response Breaking News California Governor Vetoes Biomarker Test Coverage Bill Massive Bio, Perthera Partner on Biomarker-Based Clinical Trial Matching Autolus Therapeutics, BMS Partner to Develop Cell Therapies Equipped With Safety Switches Personalis, Duke University, Olink Collaborate on Immunotherapy Markers in Gastric Cancer FDA Approves Roche Antibody Test as CDx for Enhertu in HER2-Low Breast Cancer Patients Seneca Therapeutics Cleared by FDA to Start Phase I/II Oncolytic Virus Trial
